Literature DB >> 11800270

O-glycosylation.

J F Ernst1, S K Prill.   

Abstract

O-Glycosylation in many fungal species is initiated in the endoplasmic reticulum by protein mannosyltransferases (Pmt-proteins), which transfer mannose to serine or threonine residues, and it is completed by mannosyltransferases (Mnt-proteins) in the Golgi. In this review, some recent results on O-glycosylation in the human fungal pathogen Candida albicans are discussed and compared to the corresponding knowledge in the non-pathogenic yeast Saccharomyces cerevisiae. The Pmt-family in C. albicans comprises five isoforms, of which Pmt1p and Pmt6p have been studied in detail. Surprisingly, O-glycosylation mediated by Pmt-proteins is required not only for the modification of several secreted and cell-wall proteins, but also affects yeast-hyphal morphogenesis (dimorphism) and resistance to several antifungal compounds. Furthermore, Pmt1- and Pmt6p-activities maximize adherence to host cells and determine or contribute to virulence in models of systemic infection. Thus, O-glycosylation processes directly and/or indirectly affect several virulence traits of C. albicans and can be considered as potential antifungal targets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800270

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  22 in total

1.  Pmt-mediated O mannosylation stabilizes an essential component of the secretory apparatus, Sec20p, in Candida albicans.

Authors:  Yvonne Weber; Stephan K-H Prill; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2004-10

2.  Protein O-mannosyltransferase isoforms regulate biofilm formation in Candida albicans.

Authors:  Heidrun Peltroche-Llacsahuanga; Sophie Goyard; Christophe d'Enfert; Stephan K-H Prill; Joachim F Ernst
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 3.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

4.  Transcriptional responses of Candida glabrata biofilm cells to fluconazole are modulated by the carbon source.

Authors:  Rosana Alves; Stavroula L Kastora; Alexandra Gomes-Gonçalves; Nuno Azevedo; Célia F Rodrigues; Sónia Silva; Liesbeth Demuyser; Patrick Van Dijck; Margarida Casal; Alistair J P Brown; Mariana Henriques; Sandra Paiva
Journal:  NPJ Biofilms Microbiomes       Date:  2020-01-23       Impact factor: 7.290

5.  The O-mannosyltransferase PMT4 is essential for normal appressorium formation and penetration in Ustilago maydis.

Authors:  Alfonso Fernández-Alvarez; Alberto Elías-Villalobos; José I Ibeas
Journal:  Plant Cell       Date:  2009-10-30       Impact factor: 11.277

6.  Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases.

Authors:  Mahmoud Rouabhia; Martin Schaller; Cristina Corbucci; Anna Vecchiarelli; Stephan K-H Prill; Luc Giasson; Joachim F Ernst
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 7.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

8.  Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans.

Authors:  Gillian M Olson; Deborah S Fox; Ping Wang; J Andrew Alspaugh; Kent L Buchanan
Journal:  Eukaryot Cell       Date:  2006-12-01

9.  Targeted metabolic labeling of yeast N-glycans with unnatural sugars.

Authors:  Mark A Breidenbach; Jennifer E G Gallagher; David S King; Brian P Smart; Peng Wu; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

10.  Characterization of the PMT gene family in Cryptococcus neoformans.

Authors:  Sven D Willger; Joachim F Ernst; J Andrew Alspaugh; Klaus B Lengeler
Journal:  PLoS One       Date:  2009-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.